Yasuo Ohashi

发表

Dynamic Registration Method with Balancing for Prognostic Factors in Observational Studies

Masahiro Sugihara, Satoshi Morita, Naoki Yamanouchi, 2013 .

A comparison of error detection rates between the reading aloud method and the double data entry method.

Yasuo Ohashi, Yutaka Matsuyama, Takuhiro Yamaguchi, 2003, Controlled clinical trials.

Moving a neodymium magnet promotes the migration of a magnetic tracer and increases the monitoring counts on the skin surface of sentinel lymph nodes in breast cancer

Yasuo Ohashi, Masaki Sekino, Hiroyuki Takei, 2020, BMC Medical Imaging.

University Medical Information Network - Past, Present, and Future

Kazuhiko Ohe, Yasuo Ohashi, Tsunetaro Sakurai, 1998, MedInfo.

Simultaneous clustering of cases and variables - a conceptual framework and some examples

Yasuo Ohashi, Y. Ohashi, 1987 .

When to conduct probabilistic linkage vs. deterministic linkage? A simulation study

Yasuo Ohashi, Soko Setoguchi, Ying Zhu, 2015, J. Biomed. Informatics.

A Hierarchical Regression Model for Dietary Data Adjusting for Covariates Measurement Error by Regression Calibration: An Application to a Large Prospective Study for Diabetic Complications

Yasuo Ohashi, Masataka Taguri, Nobuhiro Yamada, 2010 .

Disease-free survival as a surrogate for overall survival in adjuvant trials of gastric cancer: a meta-analysis.

Satoshi Morita, Yasuo Ohashi, Junichi Sakamoto, 2013, Journal of the National Cancer Institute.

Overlap coefficient for assessing the similarity of pharmacokinetic data between ethnically different populations

Yasuo Ohashi, Takuhiro Yamaguchi, Yutaka Matsuyama, 2005, Clinical Trials.

Adoptive immunotherapy to lower postsurgical recurrence rates of hepatocellular carcinoma: a randomised trial

Yasuo Ohashi, Michiie Sakamoto, Tadatoshi Takayama, 2000, The Lancet.

Psychosocial domain in quality of life as an independent prognostic factor for survival and tumor response in patients with advanced non-small cell lung cancer (NSCLS)

Satoshi Morita, Yasuo Ohashi, Kenji Eguchi, 2000 .

Statistical evaluation of the diagnostic accuracy of methods used to determine the progression of visual field defects in glaucoma.

Yasuo Ohashi, Hidetoshi Tsukamoto, Motohiro Shirakashi, 2004, Ophthalmology.

Benefit of Adjuvant Chemotherapy for Resectable Gastric Cancer

Yasuo Ohashi, Junichi Sakamoto, Tomasz Burzykowski, 2009 .

Adjuvant chemotherapy for gastric cancer with S-1, an oral fluoropyrimidine.

Yasuo Ohashi, Hiroshi Furukawa, Mitsuru Sasako, 2007, The New England journal of medicine.

A phase I study of combination therapy of the oral fluorinated pyrimidine compound S-1 with low-dose cisplatin twice-a-week administration (JFMC27-9902 Step2) in patients with advanced gastric cancer using a continual reassessment method.

Satoshi Morita, Yasuo Ohashi, Junichi Sakamoto, 2007, Japanese journal of clinical oncology.

Statins and risk of incident diabetes: a collaborative meta-analysis of randomised statin trials

Yasuo Ohashi, Paul Welsh, Luigi Tavazzi, 2010, The Lancet.

Predicting Macro- and Microvascular Complications in Type 2 Diabetes

Atsushi Araki, Yasuo Ohashi, Hidetoshi Yamashita, 2013, Diabetes Care.

Sectorization of the Central 30° Visual Field in Glaucoma

Yasuo Ohashi, Makoto Araie, Y. Ohashi, 1993 .

Primary prevention of cardiovascular disease with pravastatin in Japan (MEGA Study): a prospective randomised controlled trial

Yasuo Ohashi, Akira Kitabatake, Kyoichi Mizuno, 2006, The Lancet.

Role of chemotherapy for advanced/recurrent gastric cancer: an individual-patient-data meta-analysis.

Satoshi Morita, Yasuo Ohashi, Junichi Sakamoto, 2013, European journal of cancer.

Cardiorespiratory fitness as a quantitative predictor of all-cause mortality and cardiovascular events in healthy men and women: a meta-analysis.

Yasuo Ohashi, Hitoshi Shimano, Satoru Kodama, 2009, JAMA.

LINE-1 Hypomethylation Is Associated With a Poor Prognosis Among Patients With Curatively Resected Esophageal Squamous Cell Carcinoma

Yasuo Ohashi, Kentaro Sakamaki, Masayuki Watanabe, 2013, Annals of surgery.

The prognostic significance of human equilibrative nucleoside transporter 1 expression in patients with metastatic bladder cancer treated with gemcitabine‐cisplatin‐based combination chemotherapy

Yasuo Ohashi, Yasushi Nakamura, Takeshi Inagaki, 2011, BJU international.

Progression-free survival as a surrogate for overall survival in advanced/recurrent gastric cancer trials: a meta-analysis.

Satoshi Morita, Yasuo Ohashi, Junichi Sakamoto, 2013, Journal of the National Cancer Institute.

U-shaped association between body mass index and proteinuria in a large Japanese general population sample

Yasuo Ohashi, Yuji Sato, Kazuhiko Tsuruya, 2014, Clinical and Experimental Nephrology.

Long-term outcomes for neoadjuvant versus adjuvant chemotherapy in early breast cancer: meta-analysis of individual patient data from ten randomised trials

Mike Clarke, Yasuo Ohashi, Michael Gnant, 2018, The Lancet. Oncology.

Comparative validity of methods to select appropriate cutoff weight for probabilistic linkage without unique personal identifiers

Yasuo Ohashi, Jessica M Franklin, Soko Setoguchi, 2016, Pharmacoepidemiology and drug safety.

Statistical comparison of random allocation methods in cancer clinical trials.

Yasuo Ohashi, Isao Yoshimura, Chikuma Hamada, 2004, Controlled clinical trials.

Assessment of reperfused acute myocardial infarction with two-phase contrast-enhanced helical CT: prediction of left ventricular function and wall thickness.

Yasuo Ohashi, Hiroshi Higashino, Jitsuo Higaki, 2005, Radiology.